Shilpa Medicare is trading at RS. 843.95, up by 20.50 points or 2.49% from its previous closing of RS. 823.45 on the BSE.

The stock opened at RS. 823.00 and touched a high of RS. 848.00 and a low of RS. 803.00. A total of 3170 shares have been traded so far.

A BSE group 'T' stock with a face value of RS. 1, Shilpa Medicare hit a 52-week high of RS. 1003.20 on June 16, 2025, and a 52-week low of RS. 530.50 on April 7, 2025. Over the past week, its high and low stood at RS. 880.00 and RS. 803.00 respectively. The company’s current market capitalization stands at RS. 8253.06 crore.

Promoters hold 44.23% in the company, while institutions own 18.64% and non-institutions 37.13%.

In a strategic development, Shilpa Medicare’s wholly-owned subsidiary, Koanna International FZ LLC (UAE), has signed a definitive agreement with Pharma Pharmaceutical Industries & Biological Products (PPI), a leading Saudi enterprise, to establish a joint venture in Saudi Arabia. The partnership aims to set up a new pharmaceutical manufacturing facility in the Kingdom.

Under the agreement, PPI will hold a 70% stake, contributing local market expertise, while Koanna will own 30%, bringing in global R&D, manufacturing, and regulatory strengths. The venture supports Saudi Arabia’s Vision 2030 objectives of economic diversification and building a robust local healthcare infrastructure.

Shilpa Medicare specializes in producing and exporting high-quality Active Pharmaceutical Ingredients (APIs), fine chemicals, intermediates, herbal products, and specialty chemicals, adhering to stringent international standards.